Researchers find loss of certain protein is associated with poor prognosis in breast, lung cancer
Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumours and a poorer prognosis than those with high levels of the protein. Cancer arises through the increased activity of oncogenes, proteins that drive cancer growth, and the decreased activity […]